These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 3261240)
1. EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions. Stern DF; Kamps MP EMBO J; 1988 Apr; 7(4):995-1001. PubMed ID: 3261240 [TBL] [Abstract][Full Text] [Related]
2. The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade. Connelly PA; Stern DF Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6054-7. PubMed ID: 1974718 [TBL] [Abstract][Full Text] [Related]
3. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products. Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889 [TBL] [Abstract][Full Text] [Related]
4. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Stern DF; Heffernan PA; Weinberg RA Mol Cell Biol; 1986 May; 6(5):1729-40. PubMed ID: 2878363 [TBL] [Abstract][Full Text] [Related]
5. The role of the neu oncogene product in cell transformation and normal development. Kokai Y; Wada T; Myers JN; Brown VI; Dobashi K; Cohen J; Hamuro J; Weiner DB; Greene MI Princess Takamatsu Symp; 1988; 19():45-57. PubMed ID: 2908355 [TBL] [Abstract][Full Text] [Related]
6. A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation. Lehväslaiho H; Lehtola L; Sistonen L; Alitalo K EMBO J; 1989 Jan; 8(1):159-66. PubMed ID: 2565807 [TBL] [Abstract][Full Text] [Related]
7. Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene. Bargmann CI; Weinberg RA Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5394-8. PubMed ID: 2899890 [TBL] [Abstract][Full Text] [Related]
8. Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation. Galisteo ML; Dikic I; Batzer AG; Langdon WY; Schlessinger J J Biol Chem; 1995 Sep; 270(35):20242-5. PubMed ID: 7657591 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor stimulates phosphorylation of RAF-1 independently of receptor autophosphorylation and internalization. Baccarini M; Gill GN; Stanley ER J Biol Chem; 1991 Jun; 266(17):10941-5. PubMed ID: 1645717 [TBL] [Abstract][Full Text] [Related]
10. GM3 content modulates the EGF-activated p185c-neu levels, but not those of the constitutively activated oncoprotein p185neu. Sottocornola E; Berra B; Colombo I Biochim Biophys Acta; 2003 Dec; 1635(2-3):55-66. PubMed ID: 14729068 [TBL] [Abstract][Full Text] [Related]
11. TPA inhibits the tyrosine kinase activity of the neu protein in vivo and in vitro. Cao H; Decker S; Stern DF Oncogene; 1991 May; 6(5):705-11. PubMed ID: 1675782 [TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphorylation induced by epidermal growth factor and insulin-like growth factor-I in a rat clonal dental pulp-cell line. Kawase T; Orikasa M; Ogata S; Burns DM Arch Oral Biol; 1995 Oct; 40(10):921-9. PubMed ID: 8526802 [TBL] [Abstract][Full Text] [Related]
13. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling. Huang Y; Kim SO; Jiang J; Frank SJ J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595 [TBL] [Abstract][Full Text] [Related]